Reference : Targeting histone lysine demethylases - progress, challenges, and the future.
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
Targeting histone lysine demethylases - progress, challenges, and the future.
Thinnes, Cyrille [University of Oxford > Department of Chemistry]
England, Katherine S. [> >]
Kawamura, Akane [> >]
Chowdhury, Rasheduzzaman [> >]
Schofield, Christopher J. [> >]
Hopkinson, Richard J. [> >]
Biochimica et biophysica acta
Yes (verified by ORBilu)
[en] Animals ; Enzyme Inhibitors/chemistry/pharmacokinetics/therapeutic use ; Histone Demethylases/antagonists & inhibitors/chemistry/metabolism ; Humans ; Models, Molecular ; Molecular Targeted Therapy/methods ; Neoplasms/drug therapy/metabolism ; Protein Binding ; Demethylase ; Epigenetics ; Histone ; Inhibition ; Lysine ; Methylation
[en] N-Methylation of lysine and arginine residues has emerged as a major mechanism of transcriptional regulation in eukaryotes. In humans, N(epsilon)-methyllysine residue demethylation is catalysed by two distinct subfamilies of demethylases (KDMs), the flavin-dependent KDM1 subfamily and the 2-oxoglutarate- (2OG) dependent JmjC subfamily, which both employ oxidative mechanisms. Modulation of histone methylation status is proposed to be important in epigenetic regulation and has substantial medicinal potential for the treatment of diseases including cancer and genetic disorders. This article provides an introduction to the enzymology of the KDMs and the therapeutic possibilities and challenges associated with targeting them, followed by a review of reported KDM inhibitors and their mechanisms of action from kinetic and structural perspectives.
Copyright (c) 2014 Elsevier B.V. All rights reserved.

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.